Not available
Quote | Myovant Sciences Ltd. (NYSE:MYOV)
Last: | $26.98 |
---|---|
Change Percent: | -0.04% |
Open: | $26.99 |
Close: | $26.98 |
High: | $27 |
Low: | $26.98 |
Volume: | 2,256,078 |
Last Trade Date Time: | 03/09/2023 03:00:00 am |
News | Myovant Sciences Ltd. (NYSE:MYOV)
NEW YORK, NY / ACCESSWIRE / October 19, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myovant Sciences, Ltd. ("Myovant" or "the Company") (NYSE:MYOV). Investors who purchased Myovant securities are encouraged to obtain additional infor...
Myovant Sciences press release ( NYSE: MYOV ): Q3 GAAP EPS of -$0.56 beats by $0.08 . Revenue of $100.23M (+84.1% Y/Y) misses by $2.13M . Cash, cash equivalents, marketable securities, and amounts available under the Sumitomo Pharma Loan Agreement totaled $315.7 millio...
Message Board Posts | Myovant Sciences Ltd. (NYSE:MYOV)
Subject | By | Source | When |
---|---|---|---|
What a run from the $7's a few | Cosa | investorshub | 10/28/2022 9:01:02 PM |
I was hoping for $5. more a share | MDizzle | investorshub | 10/24/2022 11:50:14 AM |
Woohoo Cheers!! | Cosa | investorshub | 10/24/2022 7:17:58 AM |
Woohoo Cheers!! | Cosa | investorshub | 10/24/2022 7:17:54 AM |
Nice! patience always pays. Agree it will | Cosa | investorshub | 10/10/2022 8:05:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Myovant Sciences Ltd. Company Name:
MYOV Stock Symbol:
NYSE Market:
NEW YORK, NY / ACCESSWIRE / October 19, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myovant Sciences, Ltd. ("Myovant" or "the Company") (NYSE:MYOV). Investors who purchased Myovant securities are encouraged to obtain additional infor...
Third fiscal quarter 2022 total revenue of $100.2 million ; including net product revenue of $61.4 million Net product revenue from U.S. sales of ORGOVYX ® of $48.7 million in third fiscal quarter 2022, with sequential quarterly demand volume ...
MYOV SPECIAL ALERT: Julie & Holleman Investigates Potential Legal Claims Related to Take-Private Acquisition of Myovant Sciences MYOV SPECIAL ALERT: Julie & Holleman Investigates Potential Legal Claims Related to Take-Private Acquisition of Myovant Sciences PR Newswire ...